化合物PRI-724 T64414
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 1422253-38-0 | ¥993.00 | 询底价 |
25 mg | 1422253-38-0 | ¥2,820.00 | 询底价 |
1 mg | 1422253-38-0 | ¥412.00 | 询底价 |
10 mg | 1422253-38-0 | ¥1,570.00 | 询底价 |
2 mg | 1422253-38-0 | ¥598.00 | 询底价 |
100 mg | 1422253-38-0 | ¥6,630.00 | 询底价 |
50 mg | 1422253-38-0 | ¥4,480.00 | 询底价 |
1 mL | 1422253-38-0 | ¥1,430.00 | 询底价 |
Product Introduction
Bioactivity
英文名: PRI-724
描述: PRI-724 (C-82 prodrug)是β-catenin/CBP 相互作用的选择性小分子抑制剂。
体内活性: PRI-724 reduces liver fibrosis, and hepatic hydroxyproline levels, in HCV mice while attenuating αSMA induction. PRI-724 increased the levels of matrix metalloproteinase (MMP)-8 mRNA in the liver, along with elevated levels of intrahepatic neutrophils and macrophages/monocytes. In conclusion, PRI-724 ameliorates HCV-induced liver fibrosis in mice. PRI-724 is a drug candidate which possesses antifibrotic effect[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 55 mg/mL (83.51 mM)
Ethanol : 1.8 mg/mL (2.7 mM)
关键字: PRI724 | PRI-724 | PRI 724
相关产品: IQ 1 | PNU-74654 | TNIK-IN-7 | Nefopam hydrochloride | Adavivint | FIDAS-3 | KY19382 | Gossypolone | KY1220 | TNIK-IN-3
相关库: Drug Repurposing Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Bioactive Compounds Library Max | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Obesity Compound Library | Anti-Cancer Active Compound Library | PPI Inhibitor Library | Bioactive Compound Library
化合物PRI-724 T64414信息由TargetMol中国为您提供,如您想了解更多关于化合物PRI-724 T64414报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途